Antonella Montanini
University of Modena and Reggio Emilia(IT)Ospedale San Paolo(IT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CNS Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Viral-associated cancers and disorders, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial(2009)270 cited
- → Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial(2009)92 cited
- → Incidence, clinical characteristics and survival of malignant lymphomas: a population‐based study from a cancer registry in northern Italy(2007)60 cited
- → Long-Term Follow-Up Analysis of HD9601 Trial Comparing ABVD Versus Stanford V Versus MOPP/EBV/CAD in Patients With Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study From the Intergruppo Italiano Linfomi(2011)53 cited
- → Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)(2010)26 cited
- → Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study(2011)22 cited
- → Anthracyclines: A Cornerstone in the Management of Non-Hodgkin’s Lymphoma(2011)22 cited
- → Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by theGruppo Italiano per lo Studio dei Linfomi(2006)14 cited
- → Prognostic tools in follicular lymphomas(2009)13 cited
- → The length of treatment of aggressive non‐Hodgkin's lymphomas established according to the international prognostic index score: long‐term results of the GISL LA03 study(2006)8 cited